MedPath

OVASCIENCE INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure

Not Applicable
Suspended
Conditions
Poor Ovarian Response
Primary Ovarian Insufficiency
Interventions
Other: OvaPrime Treatment
First Posted Date
2017-01-16
Last Posted Date
2018-11-28
Lead Sponsor
OvaScience, Inc.
Target Recruit Count
81
Registration Number
NCT03021915
Locations
🇨🇦

TRIO, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath